Erlanger announces that Ryan Cleary, MD, Erlanger’s medical director for radiation oncology, has earned the 2024 Cancer Liaison Physician (CLP) Outstanding Performance Award from the American College of Surgeons Commission on Cancer (CoC). This award program recognizes outstanding performance by CLPs in their role as physician quality leaders of their cancer programs.
Officials said, "Dr. Cleary is among the eight CLPs in the country who demonstrated an exceptional understanding of the CoC standards and the National Cancer Database (NCDB) reporting tools; identified and brought forward specific issues to the hospital’s cancer committee to improve patient care; fostered a strong relationship with the American Cancer Society; and much more.
This year, more than 47 nominations were submitted."
“Dr. Cleary’s dedication to his patients and our cancer program is unparalleled,” said Janet Kramer-Mai, Erlanger’s director of oncology, “We are privileged to have him as our medical director and our cancer liaison physician and he is truly deserving of this award that is reflective of his commitment to quality, patient-centered care and program development.”
“On behalf of ACS Cancer Programs, congratulations to the winners on this well-deserved recognition for their contributions to the Commission on Cancer as a Cancer Liaison Physician,” said ACS Cancer Programs Medical Director Ronald Weigel, MD, PhD, MBA, FACS. “As the physician quality leaders at CoC-accredited hospitals, these award winners are helping to move the needle on quality care for patients with cancer.”
CLPs are responsible for evaluating, interpreting and reporting their facilities’ performance data through the NCDB and facilitating quality improvement initiatives based on data findings. In addition, the CLP is responsible for leading CoC initiatives within their cancer programs and collaborating with agencies such as the American Cancer Society on behalf of their hospital.